MyAverix Finance
US · Healthcare
Lite Strategy, Inc. (LITS)
Biotechnology
Lite Strategy, Inc. (LITS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LITS
Lite Strategy, Inc. (LITS) — FAQ
What is LITS's P/E ratio?
The price-to-earnings (P/E) ratio for Lite Strategy, Inc. (LITS) is 18.00 (data as of 2026-03-24).
Does Lite Strategy, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Lite Strategy, Inc. (LITS). Check the MyAverix Finance app for the latest dividend data.
What sector is Lite Strategy, Inc. in?
Lite Strategy, Inc. (LITS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is LITS listed on?
LITS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.